COVIGRO: Impact of COVID-19 and the vaccine against SARS-CoV-2 on the development of the placenta and the fetus
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:239 publications
Grant number: Unknown
Grant search
Key facts
Disease
COVID-19start year
2021Known Financial Commitments (USD)
$211,866.94Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
Université LavalResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)
Vulnerable Population
Pregnant women
Occupations of Interest
Unspecified
Abstract
Google translate: Scientific data regarding the impact of COVID-19 on pregnancy is limited but suggests an increase in complications such as premature birth and preeclampsia. At the same time, scientific data are limited regarding the effectiveness of the COVID-19 vaccine given during pregnancy and whether gestational age can influence its effectiveness and/or impact on the outcome of the pregnancy. We will compare two cohorts of pregnant women, one recruited before the pandemic (2017-2018) and one recruited during the 2020-2021 pandemic. Using blood samples collected at different times of pregnancy, and using a questionnaire, we will be able to establish if the patient has been infected with COVID-19 and if she has received the vaccine. We will assess the effect of COVID-19 on placental development and fetal development, as well as the rate of complications. We will finally assess whether the vaccine received during pregnancy is as effective as the vaccine received before or after pregnancy.]
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC